STARDUST SILVER

SECTION 2: Hazards identification

EMERGENCY OVERVIEW: May be fatal if swallowed. Harmful if inhaled. Harmful if absorbed through skin. Causes eye irritation. Causes skin irritation. Vapors irritating to eyes and respiratory tract. Flammable liquid and vapor. Vapors may cause flash fire or explosion. EYE: May cause severe eye irritation. SKIN: Contact with skin may cause irritation with discomfort or rash. Repeated and prolonged contact with the skin may cause allergic dermatitis. Harmful if absorbed through the skin. Skin contact may aggravate an existing dermatitis. INHALATION: Exposure to high concentrations of vapors may cause dizziness, breathing difficulty, headaches or respiratory irritation. Extremely high concentrations may cause drowsiness, staggering, confusion, unconsciousness, coma or death. Excessive inhalation of vapors can cause nasal and respiratory irritation. Liquid or vapor may be irritating to skin, eyes, throat or lungs. Intentional misuse by deliberately concentrating and inhaling the contents of this product can be harmful or fatal. Respiratory symptoms associated with pre-existing lung disorders may be aggravated by exposure to material(s) is this product. INGESTION: Moderately toxic. May cause stomach discomfort, nause, vomiting, diarrhea, and narcosis. Aspiration of material into the lungs if swallowed or if vomiting occurs can cause chemical pneumonitis which can be fatal.

Potential chronic health

Chronic overexposure to a component or components in this material has been found to cause the following effects in laboratory animals: Kidney damage Eye damage Liver damage Anemia Chronic overexposure to a component or components is this product has been suggested as a cause of the following effects in humans: Cardiac abnormalities Reports have associated repeated and prolonged overexposure to solvents with permanent brain and nervous system damage. In February 2000 the International Agency for Research on Cancer (IARC) classified ethylbenzene as possibly carcinogenic to humans (Group 2B) on the basis of sufficient evidence for carcinogenicity in experimental animals but inadequate evidence for cancer in humans. ---------------------------------------------------------------------------